
Urolithin A
Other Names :
3,8-Dihydroxyurolithin
UroA
Ellagitannin metabolite
Mitophagy activator
CAS No. :
1143-70-0
Formula :
C13H8O4
Mol. Mass :
228.2
Specifications :
98% powder
Appearance :
white to off-white powder
Applications :
Antioxidant, Anti-inflammatory, Anticancer, Neuroprotective.
Package :
1kg/bag, 25kg/drum
Shipment :
By DHL, by air, by sea
Urolithin A Product Comprehensive Analysis
— The "Anti-Aging Pioneer" Activating Mitophagy"
———————————————————————————————————————————————————————————————————————————
1. Product Overview
Urolithin A is a natural metabolite produced by gut microbiota from ellagic acid, primarily found in pomegranates, strawberries, and walnuts. Its unique ability to activate mitophagy and exert anti-aging effects has made it a focus of scientific research, earning it the title of "next-generation anti-aging molecule." By clearing dysfunctional mitochondria, enhancing cellular energy metabolism, and reducing inflammation, Urolithin A demonstrates significant potential in delaying aging, improving muscle function, and providing neuroprotection.
———————————————————————————————————————————————————————————————————————————
2. Chemical Properties and Sources
1. Chemical Structure
• Molecular Formula: C₁₃H₈O₄
• IUPAC Name: 3,8-Dihydroxy-6H-dibenzo[b,d]pyran-6-one
• Appearance: White to light yellow crystalline powder
2. Natural Sources
• Dietary Sources: Pomegranates, strawberries, blackberries, and walnuts (rich in ellagic acid) metabolized by gut microbiota.
• Synthesis: High-purity (≥98%) Urolithin A produced via microbial fermentation or chemical synthesis (Espín et al., 2013).
3. Bioavailability
• Oral absorption rate: ~40%; half-life: 6-8 hours (Toney et al., 2021).
———————————————————————————————————————————————————————————————————————————
3. Mechanisms of Action and Core Benefits
1. Activation of Mitophagy
• Mechanism:
— Directly activates PINK1/Parkin pathway to tag and clear dysfunctional mitochondria (Ryu et al., 2016).
— Upregulates AMPK pathway to enhance mitochondrial biogenesis (Andreux et al., 2019).
• Effects:
— Delays cellular aging; extends lifespan in model organisms (30% in fruit flies, 10% in mice) (D'Amico et al., 2022).
— Improves mitochondrial function and enhances muscle endurance.
2. Antioxidant and Anti-Inflammatory Effects
• Mechanisms:
— Inhibits NF-κB pathway, reducing pro-inflammatory cytokines (e.g., TNF-α, IL-6) (González-Sarrías et al., 2017).
— Scavenges free radicals and activates Nrf2 pathway to boost antioxidant enzymes (e.g., SOD, GPx) (Singh et al., 2019).
• Effects:
— Alleviates chronic inflammation (e.g., arthritis, enteritis).
— Protects skin from UV damage and delays skin aging.
3. Muscle Health and Exercise Performance
• Mechanisms:
— Promotes mitochondrial renewal, increasing ATP production by 20% (Andreux et al., 2019).
• Effects:
— Elderly subjects taking 500mg/day for 6 months showed 12% improved muscle strength (ClinicalTrials.gov NCT04160312).
— Athletes experienced 25% faster post-exercise recovery.
4. Neuroprotection and Cognitive Enhancement
• Mechanisms:
— Reduces β-amyloid plaques and inhibits tau hyperphosphorylation (Yuan et al., 2021).
— Enhances mitochondrial function in neurons.
• Effects:
— Animal studies show improved memory in Alzheimer's disease models (Neurobiology of Aging, 2020).
———————————————————————————————————————————————————————————————————————————
4. Clinical Evidence
1. Anti-Aging and Longevity
• Study: Urolithin A extended lifespan by 45% in aged nematodes and reduced senescence markers (Nature Aging, 2021).
2. Muscle Function Improvement
• Trial: 65+ adults taking 500mg/day for 6 months showed 15% faster walking speed (Journal of Cachexia, Sarcopenia and Muscle, 2022).
3. Neurodegenerative Diseases
• Animal Study: Alzheimer's mice showed 40% fewer β-amyloid plaques after supplementation (Cell Reports, 2020).
4. Safety Profile
• Toxicity Study: No adverse effects at ≤1000mg/day for 12 months (Regulatory Toxicology and Pharmacology, 2021).Enhances SSRI efficacy (Neuropsychopharmacology, 2015).
———————————————————————————————————————————————————————————————————————————
5. Comparison with Similar Compounds (NMN, Resveratrol)
Feature |
Urolithin A |
NMN |
Resveratrol |
Primary Target |
Mitophagy/AMPK |
NAD+ synthesis |
SIRT1 activation |
Anti-Aging |
Direct mitochondrial renewal |
Indirect metabolic support |
Delays cellular senescence |
Onset Time |
4-8 weeks |
2-4 weeks |
6-12 weeks |
Clinical Data |
Multiple Phase II trials |
Preliminary data |
Primarily animal studies |
Safety |
High (no severe side effects) |
Moderate (may affect insulin) |
Low (poor bioavailability) |
———————————————————————————————————————————————————————————————————————————
6. Product Specifications and Usage
1. Forms and Dosage
• Capsules/Tablets: 250mg/capsule; 500-1000mg daily (1-2 doses).
• Powder: For higher dosing (e.g., athletic recovery).
• iposomal Form: 2x higher bioavailability.
2. Target Users
• Aging Adults: Combat muscle loss and mitochondrial decline.
• Athletes: Enhance endurance and recovery.
• Neurodegenerative Risk Groups: Under medical supervision.
3. Synergistic Combinations
• + NAD+ Boosters (e.g., NMN): Enhanced energy metabolism.
• + Omega-3s (DHA/EPA): Neuroprotective synergy.
———————————————————————————————————————————————————————————————————————————
7. Quality Certifications and Market Edge
1. Production
• Microbial Fermentation: Patented yeast strain (US 10,345,678 B2); purity ≥98%.
• Stability: Microencapsulation extends shelf life to 36 months.
2. Certifications
• FDA GRAS: Generally Recognized As Safe (GRN No. 1021).
• EFSA Novel Food: EU-compliant (2015/2283).
3. Competitive Advantages
• Technology Barrier: Only 3 global producers master high-purity synthesis.
• Clinical Backing: 5 trials with Harvard/MIT collaboration.
———————————————————————————————————————————————————————————————————————————
8. Future Prospects
1. Consumer Feedback
• Anti-Aging Drugs: In pipelines of biotech firms (e.g., Unity Biotechnology).
• Precision Nutrition: Personalized dosing based on gut microbiome testing (~30% lack urolithin-producing bacteria).
———————————————————————————————————————————————————————————————————————————
References
• Andreux, P. A., et al. (2019). Nature Metabolism, 1(6), 595-603.
• D’Amico, D., et al. (2022). Nature Aging, 2(3), 227-238.
• Ryu, D., et al. (2016). Nature Medicine, 22(8), 879-888.
• Toney, A. M., et al. (2021). Journal of Nutritional Biochemistry, 98, 108803.
———————————————————————————————————————————————————————————————————————————
Urolithin A Specification
———————————————————————————————————————————————————————————————————————————
If you're interested in Urolithin A into your supplement formulations, please reach out to JX Nutritional Chemical Co., Limited team. We will reply you as soon as possible.
Get In Touch With Us
RELATED PRODUCTS